|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Estimating the world cancer burden: Globocan 2000. Int J Cancer.
94:153–156. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
El-Serag HB and Mason AC: Rising incidence
of hepatocellular carcinoma in the United States. N Engl J Med.
340:745–750. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ikai I, Yamaoka Y, Yamamoto Y, et al:
Surgical intervention for patients with stage IV-A hepatocellular
carcinoma without lymph node metastasis: proposal as a standard
therapy. Ann Surg. 227:433–439. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee JS, Chu IS, Heo J, Calvisi DF, et al:
Classification and prediction of survival in hepatocellular
carcinoma by gene expression profiling. Hepatology. 40:667–676.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Song HY, Liu YK, Feng JT, et al: Proteomic
analysis on metastasis-associated proteins of human hepatocellular
carcinoma tissues. J Cancer Res Clin Oncol. 132:92–98. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shukla Y: Tea and cancer chemoprevention:
a comprehensive review. Asian Pacific J Cancer Prev. 8:155–165.
2007.PubMed/NCBI
|
|
7
|
Yang CS, Wang X, Lu G and Picinich SC:
Cancer prevention by tea: animal studies, molecular mechanisms and
human relevance. Nat Rev Cancer. 9:429–439. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang CS and Wang ZY: Tea and cancer. J
Natl Cancer Inst. 85:1038–1049. 1993. View Article : Google Scholar
|
|
9
|
Balentine DA, Wiseman SA and Bouwens LCM:
The chemistry of tea flavonoids. Crit Rev Food Sci Nutr.
37:693–704. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mukhtar H and Ahmad N: Green tea in
chemoprevention of cancer. Toxicol Sci. 52:111–117. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh BN, Shankar S and Srivastava RK:
Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms,
perspectives and clinical applications. Biochem Pharmacol.
82:1807–1821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Thawonsuwan J, Kiron V, Satoh S, et al:
Epigallocatechin-3-gallate (EGCG) affects the antioxidant and
immune defense of the rainbow trout, Oncorhynchus mykiss.
Fish Physiol Biochem. 36:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mukhtar H and Ahmad N: Tea polyphenols:
prevention of cancer and optimizing health. Am J Clin Nutr.
71(Suppl 6): S1698–S1702. 2000.PubMed/NCBI
|
|
14
|
Thangapazham RL, Singh AK, Sharma A, et
al: Green tea polyphenols and its constituent epigallocatechin
gallate inhibits proliferation of human breast cancer cells in
vitro and in vivo. Cancer Lett. 245:232–241. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shankar S, Ganapathy S, Hingorani SR and
Srivastava RK: EGCG inhibits growth, invasion, angiogenesis and
metastasis of pancreatic cancer. Front Biosci. 13:440–452. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stuart EC, Scandlyn MJ and Rosengren RJ:
Role of epigallocatechin gallate (EGCG) in the treatment of breast
and prostate cancer. Life Sci. 79:2329–2336. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sen T, Moulik S, Dutta A, et al:
Multifunctional effect of epigallocatechin-3-gallate (EGCG) in
downregulation of gelatinase-A (MMP-2) in human breast cancer cell
line MCF-7. Life Sci. 84:194–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee SJ, Lee KW, Hur HJ, Chun JY, Kim SY
and Lee HJ: Phenolic phytochemicals derived from red pine (Pinus
densiflora) inhibit the invasion and migration of SK-Hep-1
human hepatocellular carcinoma cells. Ann NY Acad Sci.
1095:536–544. 2007.PubMed/NCBI
|
|
19
|
Woodhouse EC, Chuaqui RF and Liotta LC:
General mechanisms of metastasis. Cancer. 80(Suppl 8): S1529–S1537.
1997. View Article : Google Scholar
|
|
20
|
Hidalgo M and Eckhardt SG: Development of
matrix metalloproteinase inhibitors in cancer therapy. J Natl
Cancer Inst. 93:178–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duncan R, Bazar L, Michelotti G, Tomonaga
T, Krutzsch H, Avigan M and Levens D: A sequence-specific,
single-strand binding protein activates the far upstream element of
c-myc and defines a new DNA-binding motif. Genes Dev. 8:465–480.
1994. View Article : Google Scholar
|
|
22
|
Zubaidah RM, Tan GS, Tan SB, Lim SG, Lin Q
and Chung MC: 2-D DIGE profiling of hepatocellular carcinoma
tissues identified isoforms of far upstream binding protein (FUBP)
as novel candidates in liver carcinogenesis. Proteomics.
8:5086–5096. 2008. View Article : Google Scholar
|
|
23
|
Sanz R, Aragüés R, Stresing V, Martín B,
Landemaine T, Oliva B, et al: Functional pathways shared by liver
and lung metastases: a mitochondrial chaperone machine is
up-regulated in soft-tissue breast cancer metastasis. Clin Exp
Metastasis. 24:673–683. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hansen RK, Parra I, Hilsenbeck SG,
Himelstein B and Fuqua SA: Hsp27-induced MMP-9 expression in
influenced by the Src tyrosine protein kinase yes. Biochem Biophys
Res Commun. 282:186–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gibert B, Eckel B, Gonin V, Goldschneider
D, Fombonne J, Deux B, et al: Targeting heat shock protein 27
(HspB1) interferes with bone metastasis and tumour formation in
vivo. Br J Cancer. 107:63–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanna B, Debidda M, Pintus G, et al: The
anti-metastatic agent imidazolium
trans-imidazoledimethylsulfoxide-tetrachlororuthenate induces
endothelial cell apoptosis by inhibiting the mitogen-activated
protein kinase/extracellular signal-regulated kinase signaling
pathway. Arch Biochem Biophys. 403:209–218. 2002. View Article : Google Scholar
|
|
27
|
Borer RA, Lehner CF, Eppenberger HM and
Nigg EA: Major nucleolar proteins shuttle between nucleus and
cytoplasm. Cell. 56:379–390. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maggi LB Jr, Kuchenruether M, Dadey DY,
Schwope RM, Grisendi S, Townsend RR, et al: Nucleophosmin serves as
a rate-limiting nuclear export chaperone for the Mammalian
ribosome. Mol Cell Biol. 28:7050–7065. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yung BY, Bor AM and Chan PK: Short
exposure to actinomycin D induces ‘reversible’ translocation of
protein B23 as well as ‘reversible’ inhibition of cell growth and
RNA synthesis in HeLa cells. Cancer Res. 50:5987–5991. 1990.
|
|
30
|
Chan PK and Chan FY: A study of
correlation between NPM-translocation and apoptosis in cells
induced by daunomycin. Biochem Pharmacol. 57:1265–1273. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Herkert B, Dwertmann A, Herold S, Abed M,
Naud JF, Finkernagel F, et al: The Arf tumor suppressor protein
inhibits Miz1 to suppress cell adhesion and induce apoptosis. J
Cell Biol. 188:905–918. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Feng Y, Tian ZM, Wan MX and Zheng ZB:
Protein profile of human hepatocarcinoma cell line SMMC-7721:
identification and functional analysis. World J Gastroenterol.
13:2608–2614. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang D, Ying W, Lu Y, Wan J, Zhai Y, Liu
W, et al: Identification of metastasis-associated proteins by
proteomic analysis and functional exploration of interleukin-18 in
metastasis. Proteomics. 3:724–737. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tsai YP, Yang MH, Huang CH, et al:
Interaction between HSP60 and beta-catenin promotes metastasis.
Carcinogenesis. 30:1049–1057. 2009. View Article : Google Scholar : PubMed/NCBI
|
